Oxidative stress early in pregnancy and pregnancy outcome

Free Radical Research

Volumn 42, Issue 10, 2008, Pages 841-848

  Stein, T Peter ^a   Scholl, Theresa O ^a   Schluter, Margaret D ^a   Leskiw, Maria J ^a   Chen, Xinhua ^a   Spur, Bernd W ^a   Rodriguez, Ana ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

8 hydroxy 2 deoxyguanosine; Dietary antioxidants; GPx; Isoprostane; Oxidative stress; Pregnancy; SOD

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; CREATININE; DNA; FERRITIN; GLUTATHIONE PEROXIDASE; IRON; ISOPROSTANE; LIPID; SUPEROXIDE DISMUTASE;

ADULT; AFRICAN AMERICAN; ARTICLE; BIRTH DEFECT; BIRTH WEIGHT; CAUCASIAN; CHILDBIRTH; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FOOD INTAKE; GAS CHROMATOGRAPHY; GESTATION PERIOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISPANIC; HUMAN; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEDICAID; OXIDATION; OXIDATIVE STRESS; PARITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; RISK ASSESSMENT; UNITED STATES; URINARY EXCRETION;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BIRTH WEIGHT; CONGENITAL ABNORMALITIES; DEOXYGUANOSINE; DINOPROST; DNA DAMAGE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 55849149026     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802510069     Document Type: Article

References (43)

1. Gitto, E., Reiter, RJ., Karbownik, M., Tan, DX., Gitto, P., Barberi, S. and Barberi, I. (2002) Causes of oxidative stress in the pre- and perinatal period. Biol Neonate, 81, pp. 146-157.
2. Halliwell, B. (1997) Antioxidants and human disease: A general introduction. Nutr Rev, 55, pp. S44-S52.
3. Roberts, JM and Hubel, CA. (2004) Oxidative stress in preeclampsia. Am J Obstr Gynecol, 190, pp. 1177-1178.
4. Roberts, JM., Pearson, GD., Cutler, JA. and Lindheimer, MD. (2003) Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension Pregnancy, 22, pp. 109-127.
5. Williams, MA., Woelk, GB., King, IB., Jenkins, L. and Mahomed, K. (2003) Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertension, 16, pp. 665-672.
6. Scholl, TO, Leskiw, M., Chen, X., Sims, M. and Stein, TP. (2005) Oxidative stress, diet, and the etiology of preeclampsia. Am J Clin Nutr, 81, pp. 1390-1396.
7. Facchini, FS, Hua, N., Abbasi, F. and Reaven, GM. (2001) Insulin resistance as a predictor of age-related diseases. J Clin Endo Metab, 86, pp. 3574-3578.
8. Hofman, PL., Regan, F., Jackson, WE., Jefferies, C., Knight, DB., Robinson, EM. and Cutfield, WS. (2004) Premature birth and later insulin resistance. New Engl J Med, 351, pp. 2179-2186.
9. Frank, L. and Groseclose, EE. (1984) Preparation for birth into an O2-rich environment: The antioxidant enzymes in the developing rabbit lung. Pediatr Res, 18, pp. 240-244.
10. de Haan, JB, Tymms, MJ, Cristiano, F. and Kola, I. (1994) Expression of copper/zinc superoxide dismutase and glutathione peroxidase in organs of developing mouse embryos, fetuses, and neonates. Pediatr Res, 35, pp. 188-196.
11. Angerer, J., Ewers, U. and Wilhelm, M. (2007) Human biomonitoring: State of the art. Int J Hyg Environ Health, 210, pp. 201-228.
12. Poulsen, HE. (2005) Oxidative DNA modifications. Exp Toxicol Pathol, 57, pp. 161-169.
13. Kadiiska, MB., Gladen, BC., Baird, DD., Germolec, D., Graham, LB., Parker, CE., Nyska, A., Wachsman, JT., Ames, BN., Basu, S., Brot, N., Fitzgerald, GA., Floyd, RA., George, M., Heinecke, JW., Hatch, GE., Hensley, K., Lawson, JA., Marnett, LJ., Morrow, JD., Murray, DM., Plastaras, J., Roberts 2nd, LJ, Rokach, J., Shigenaga, MK., Sohal, RS., Sun, J., Tice, RR., Van Thiel, DH., Wellner, D., Walter, PB., Tomer, KB., Mason, RP. and Barrett, JC. (2005) Biomarkers of oxidative stress study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med, 38, pp. 698-710.
14. Block, G., Dietrich, M., Norkus, EP., Morrow, JD., Hudes, M., Caan, B. and Packer, L. (2002) Factors associated with oxidative stress in human populations. Am J Epidemiol, 156, pp. 274-285.
15. Roberts 2nd, LJ, Fessel, JP and Davies, SS. (2005) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol, 15, pp. 143-148.
16. Zhang, J. and Bowes Jr, WA (1995) Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol, 86, pp. 200-208.
17. Jagota, SK and Dani, HM. (1982) A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent. Anal Biochem, 127, pp. 178-182.
18. Bieri, JG, Tolliver, TJ and Catignani, GL. (1979) Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography. Am J Clin Nutr, 32, pp. 2143-2149.
19. Lin, HS., Jenner, AM., Ong, CN., Huang, SH., Whiteman, M. and Halliwell, B. (2004) A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2′-deoxyguanosine: Measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem J, 380, pp. 541-548.
20. Schwedhelm, E. and Boger, RH. (2003) Application of gas chromatography-mass spectrometry for analysis of isoprostanes: Their role in cardiovascular disease. Clin Chem Lab Med, 41, pp. 1552-1561.
21. Il'yasova, D., Morrow, JD, Ivanova, A. and Wagenknecht, LE. (2004) Epidemiological marker for oxidant status: Comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Ann Epidemiol, 14, pp. 793-797.
22. Hermanns, RCA., Zomer, G., Jacqemijns, M., Stavenuiter, JG., Westa, AJR. and Van de Werken, G. (1994) Synthesis of 8-[18O] hydroxyl-2′-deoxyguanosine. J Labelled Compounds, 34, pp. 191-197.
23. Gannett, PM. and Sura, TP. (1993) An improved synthesis of 8-Bromo-2-deoxyguanosine. Syn Comm, 23, pp. 1611-1615.
24. McCarthy, C., Cotter, FE., McElwaine, S., Twomey, A., Mooney, EE., Ryan, F. and Vaughan, J. (2007) Altered gene expression patterns in intrauterine growth restriction: Potential role of hypoxia. Am J Obst Gynecol, 196, p. e71.
25. Smith, GC., Shah, I., White, IR., Pell, JP., Crossley, JA. and Dobbie, R. (2007) Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG: Int J Obstet Gynaecol, 114, pp. 705-714.
26. Mizoue, T., Tokunaga, S., Kasai, H., Kawai, K., Sato, M. and Kubo, T. (2007) Body mass index and oxidative DNA damage: A longitudinal study. Cancer Sci, 98, pp. 1254-1258.
27. Loft, S., Vistisen, K., Ewertz, M., Tjonneland, A., Overvad, K. and Poulsen, HE. (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis, 13, pp. 2241-2247.
28. Kasai, H., Iwamoto-Tanaka, N., Miyamoto, T., Kawanami, K., Kawanami, S., Kido, R. and Ikeda, M. (2001) Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative dna damage: Effects of exercise, working conditions, meat intake, body mass index, and smoking. Jap J Can Res, 92, pp. 9-15.
29. Loft, S., Astrup, A., Buemann, B. and Poulsen, HE. (1994) Oxidative DNA damage correlates with oxygen consumption in humans. Faseb J, 8, pp. 534-537.
30. Ekelund, U., Aman, J., Yngve, A., Renman, C., Westerterp, K. and Sjostrom, M. (2002) Physical activity but not energy expenditure is reduced in obese adolescents: A case-control study. [see comment]. Am J Clin Nutr, 76, pp. 935-941.
31. Lazzer, S., Boirie, Y., Bitar, A., Montaurier, C., Vernet, J., Meyer, M. and Vermorel, M. (2003) Assessment of energy expenditure associated with physical activities in free-living obese and nonobese adolescents. Am J Clin Nutr, 78, pp. 471-479.
32. Yoshioka, M., Ayabe, M., Yahiro, T., Higuchi, H., Higaki, Y., St-Amand, J., Miyazaki, H., Yoshitake, Y., Shindo, M. and Tanaka, H. (2005) Long-period accelerometer monitoring shows the role of physical activity in overweight and obesity. Int J Obesity, 29, pp. 502-508.
33. Institute of Medicine (1990)National Academy Press, Washington, DC
34. Kim, YJ., Hong, YC., Lee, KH., Park, HJ., Park, EA., Moon, HS. and Ha, EH. (2005) Oxidative stress in pregnant women and birth weight reduction. Repr Toxicol, 19, pp. 487-492.
35. Scholl, TO and Stein, TP. (2001) Oxidant damage to DNA and pregnancy outcome. J Matern Fetal Med, 10, pp. 182-185.
36. Crider, KS, Whitehead, N. and Buus, RM. (2005) Genetic variation associated with preterm birth: A HuGE review. Genet Med, 7, pp. 593-604.
37. Paz-Elizur, T., Krupsky, M., Blumenstein, S., Elinger, D., Schechtman, E. and Livneh, Z. (2003) DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst, 95, pp. 1312-1319.
38. Bruner, SD, Norman, DP and Verdine, GL. (2000) Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, 403, pp. 859-866.
39. Chappell, LC., Seed, PT., Kelly, FJ., Briley, A., Hunt, BJ., Charnock-Jones, DS., Mallet, A. and Poston, L. (2005) Screening test for pre-eclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obst Gyn, 193, pp. 1486-1491.
40. Parra, M., Rodrigo, R., Barja, P., Bosco, C., Fernandez, V., Munoz, G. and Soto-Chacone, E. (2005) Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol, 187, pp. 777-784.
41. Cracowski, JL, Devillier, P., Durand, T., Stanke-Labesque, F. and Bessard, G. (2001) Vascular biology of the isoprostanes. J Vascular Res, 38, pp. 93-103.
42. Hou, X., Roberts 2nd, LJ, Gobeil Jr, F., Taber, D., Kanai, K., Abran, D., Brault, S., Checchin, D., Sennlaub, F., Lachapelle, P., Varma, D. and Chemtob, S. (2004) Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic Biol Med, 36, pp. 163-172.
43. Kromer, BM and Tippins, JR. (1996) Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharm, 119, pp. 1276-1280.